NCT03576638View on ClinicalTrials.gov

Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Parkinson Disease
Interventions
DRUG

Accordion Pill Carbidopa/Levodopa

AP 50/500 TID days 2-7

DRUG

Sinemet CR 25Mg-100Mg Extended-Release Tablet

25/100 1.5 pills five times/day

Sponsors

Lead Sponsor

Intec Pharma Ltd.
All Listed Sponsors
lead

Intec Pharma Ltd.

INDUSTRY

NCT03576638 - Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients | Biotech Hunter | Biotech Hunter